CLINICAL IMPACT OF RECURRENTLY MUTATED GENES ON LYMPHOMA DIAGNOSTICS: STATE-OF-THE-ART AND BEYOND

Rosenquist R, Rosenwald A, Du MQ, Gaidano G, Groenen P, Wotherspoon A, Ghia P, Gaulard P, Campo E, Stamatopoulos K; European Research Initiative on CLL (ERIC) and the European Association for Haematopathology (EAHP).

Haematologica. 2016 Sep;101(9):1002-9. doi: 10.3324/haematol.2015.134510

DIFFERENT SPECTRA OF RECURRENT GENE MUTATIONS IN SUBSETS OF CHRONIC LYMPHOCYTIC LEUKEMIA HARBORING STEREOTYPED B-CELL RECEPTORS

Sutton LA, Young E, Baliakas P, Hadzidimitriou A, Moysiadis T, Plevova K, Rossi D, Kminkova J, Stalika E, Pedersen LB, Malcikova J, Agathangelidis A, Davis Z, Mansouri L, Scarfò L, Boudjoghra M, Navarro A, Muggen AF, Yan XJ, Nguyen-Khac F, Larrayoz M, Panagiotidis P, Chiorazzi N, Niemann CU, Belessi C, Campo E, Strefford JC, Langerak AW, Oscier D, Gaidano G, Pospisilova S, Davi F, Ghia P, Stamatopoulos K, Rosenquist R; ERIC, the European Research Initiative on CLL.

Haematologica. 2016 Aug;101(8):959-67. doi: 10.3324/haematol.2016.141812. Epub 2016 May 19.

TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH DEL(17P)/TP53 MUTATION: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION OR BCR-SIGNALING INHIBITORS?

TRANSPLANTATION IN CLL: WHAT WE CAN LEARN FROM A DINOSAUR

OPTIMIZATION AND VALIDATION OF AN 8-COLOR SINGLE-TUBE ASSAY FOR THE SENSITIVE DETECTION OF MINIMAL RESIDUAL DISEASE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA DETECTED VIA FLOW CYTOMETRY

Dowling AK, Liptrot SD, O’Brien D, Vandenberghe E.

Lab Med. 2016 May;47(2):103-11. doi: 10.1093/labmed/lmw006.

A COMPLEMENTARY ROLE OF MULTIPARAMETER FLOW CYTOMETRY AND HIGH-THROUGHPUT SEQUENCING FOR MINIMAL RESIDUAL DISEASE DETECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA: AN EUROPEAN RESEARCHINITIATIVE ON CLL STUDY

Rawstron AC, Fazi C, Agathangelidis A, Villamor N, Letestu R, Nomdedeu J, Palacio C, Stehlikova O, Kreuzer KA, Liptrot S, O’Brien D, de Tute RM, Marinov I, Hauwel M, Spacek M, Dobber J, Kater AP, Gambell P, Soosapilla A, Lozanski G, Brachtl G, Lin K, Boysen J, Hanson C, Jorgensen JL, Stetler-Stevenson M, Yuan C, Broome HE, Rassenti L, Craig F, Delgado J, Moreno C, Bosch F, Egle A, Doubek M, Pospisilova S, Mulligan S, Westerman D, Sanders CM, Emerson R, Robins HS, Kirsch I, Shanafelt T, Pettitt A, Kipps TJ, Wierda WG, Cymbalista F, Hallek M, Hillmen P, Montserrat E, Ghia P

Leukemia. 2016 Apr;30(4):929-36. doi: 10.1038/leu.2015.313. Epub 2015 Dec 7.

INNOVATION IN THE PROGNOSTICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA: HOW FAR BEYOND TP53 GENEANALYSIS CAN WE GO?

Pospisilova S, Sutton LA, Malcikova J, Tausch E, Rossi D, Montserrat E, Moreno C, Stamatopoulos K, Gaidano G, Rosenquist R, Ghia P, on behalf of the European Research Initiative on CLL (ERIC)

Haematologica. 2016 Mar;101(3):263-5. doi: 10.3324/haematol.2015.139246.